Apellis Pharmaceuticals Inc to Discuss the CHMP Trend Vote Transcript
Good day, and welcome to the Apellis update call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to turn the call over to Meredith Kaya, you may begin.
Good morning, and thank you for joining us to discuss our announcement this morning regarding the CHMP trend vote. With me on the call are Co-Founder and Chief Executive Officer, Dr. Cedric Francois; Chief Medical Officer, Dr. Caroline Baumal, and Chief Financial Officer, Tim Sullivan; Adam Townsend, Chief Commercial Officer, is with the European team in Switzerland right now and unable to join the call this morning.
Before we begin, let me point out that we will be making forward-looking statements that are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail. Now I'll turn the call over to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |